2FNC1†These authors contributed equally to this work.
2FNC‡Present address: University of Edinburgh Medical School, Division of Pathway Medicine, Chancellors Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK.
SCC12F cells are a line of keratinocytes that retain the capacity for terminal differentiation in vitro. We showed previously that the Epstein–Barr virus (EBV)-encoded oncogene latent membrane protein 1 (LMP1) altered SCC12F morphology in vitro, downregulated cell–cell-adhesion molecule expression and promoted cell motility. In organotypic raft culture, LMP1-expressing cells failed to stratify and formed poorly organized structures which displayed impaired terminal differentiation. To understand better the mechanism(s) by which LMP1 induces these effects, we generated SCC12F cells in which LMP1 expression is inducible. Following induction, these cells exhibited phenotypic changes similar to those observed previously and allowed us to investigate the effects of LMP1 expression on cellular pathways associated with growth, differentiation and morphology. Using microarrays and a number of confirmatory techniques, we identified sets of differentially expressed genes that are characteristically expressed in inflammatory and hyperproliferative epidermis, including chemokines, cytokines and their receptors, growth factors involved in promoting epithelial cell motility and proliferation and signalling molecules that regulate actin filament reorganization and cell movement. Among the genes whose expression was differentially induced significantly by LMP1, the induction of IL-1β and IL-1α was of particular interest, as many of the LMP1-regulated genes identified are established targets of these cytokines. Our findings suggest that alterations in the IL-1 signalling network may be responsible for many of the changes in host-cell gene expression induced in response to LMP1. Identification of these LMP1-regulated genes helps to define the mechanism(s) by which this oncoprotein influences cellular pathways that regulate terminal differentiation, cell motility and inflammation.
BambergerC.,
ScharerA.,
AntsiferovaM.,
TychsenB.,
PankowS.,
MullerM.,
RulickeT.,
PausR.,
WernerS.2005; Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes. Am J Pathol 167:733–747[CrossRef]
BellA. I.,
GrovesK.,
KellyG. L.,
Croom-CarterD.,
HuiE.,
ChanA. T. C.,
RickinsonA. B.2006; Analysis of Epstein–Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87:2885–2890[CrossRef]
BreitlingR.,
ArmengaudP.,
AmtmannA.,
HerzykP.2004; Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573:83–92[CrossRef]
BussonP.,
GanemG.,
FloresP.,
MugneretF.,
ClausseB.,
CaillouB.,
BrahamK.,
WakasugiH.,
LipinskiM.,
TurszT.1988; Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 42:599–606[CrossRef]
CheungS. T.,
HuangD. P.,
HuiA. B. Y.,
LoK. W.,
TsangY. S.,
WongN.,
WhitneyB. M.,
LeeJ. C. K.1999; Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 83:121–126[CrossRef]
DawsonC. W.,
EliopoulosA. G.,
BlakeS. M.,
BarkerR.,
YoungL. S.2000; Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells. Virology 272:204–217[CrossRef]
EliopoulosA. G.,
StackM.,
DawsonC. W.,
KayeK. M.,
HodgkinL.,
SihotaS.,
RoweM.,
YoungL. S.1997; Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene 14:2899–2916[CrossRef]
EverlyD. N.Jr,
MainouB. A.,
Raab-TraubN.2004; Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol 78:13470–13478[CrossRef]
FåhraeusR.,
ChenW.,
TrivediP.,
KleinG.,
ObrinkB.1992; Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int J Cancer 52:834–838[CrossRef]
FloettmannJ. E.,
WardK.,
RickinsonA. B.,
RoweM.1996; Cytostatic effect of Epstein–Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223:29–40[CrossRef]
GrovesR. W.,
MizutaniH.,
KiefferK. D.,
KupperT. S.1995; Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci U S A 92:11874–11880[CrossRef]
GutschalkC. M.,
Herold-MendeC. C.,
FusenigN. E.,
MuellerM. M.2006; Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res 66:8026–8036[CrossRef]
HaaseI.,
HobbsR. M.,
RomeroM. R.,
BroadS.,
WattF. M.2001; A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108:527–536[CrossRef]
Hellung SchønningB.,
BévortM.,
MikkelsenS.,
AndresenM.,
ThomsenP.,
LeffersH., NorrildB.2000; Human papillomavirus type 16 E7-regulated genes: regulation of S100P and ADP/ATP carrier protein genes identified by differential-display technology. J Gen Virol 81:1009–1015
HobbsR. M.,
Silva-VargasV.,
GrovesR.,
WattF. M.2004; Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions. J Invest Dermatol 123:503–515[CrossRef]
ImaiK.,
KumagaiS.,
NakagawaK.,
YamamotoE.,
NakanishiI.,
OkadaY.1995; Immunolocalization of desmoglein and intermediate filaments in human oral squamous cell carcinomas. Head Neck 17:204–212[CrossRef]
IrizarryR. A.,
BolstadB. M.,
CollinF.,
CopeL. M.,
HobbsB.,
SpeedT. P.2003; Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15[CrossRef]
JohansenC.,
FlindtE.,
KragballeK.,
HenningsenJ.,
WestergaardM.,
KristiansenK.,
IversenL.2005; Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. J Invest Dermatol 124:1284–1292[CrossRef]
KeelanJ. A.,
GroomeN. P.,
MitchellM. D.1998; Regulation of activin-A production by human amnion, decidua and placenta in vitro by pro-inflammatory cytokines. Placenta 19:429–434[CrossRef]
KlementJ. F.,
RiceN. R.,
CarB. D.,
AbbondanzoS. J.,
PowersG. D.,
BhattH.,
ChenC.-H.,
RosenC. A.,
StewartC. L.1996; I κ B α deficiency results in a sustained NF- κ B response and severe widespread dermatitis in mice. Mol Cell Biol 16:2341–2349
LiC.,
WongW. H.2001; Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 98:31–36[CrossRef]
LiY.,
LiT.,
LiuS.,
QiuM.,
HanZ.,
JiangZ.,
LiR.,
YingK.,
XieY.,
MaoY.2004b; Systematic comparison of the fidelity of aRNA, mRNA and T-RNA on gene expression profiling using cDNA microarray. J Biotechnol 107:19–28[CrossRef]
LivakK. J.,
SchmittgenT. D.2001; Analysis of relative gene expression data using real-time quantitative PCR and the [inline-graphic]method. Methods 25:402–408.[/inline-graphic][CrossRef]
MeeJ. B.,
JohnsonC. M.,
MorarN.,
BurslemF.,
GrovesR. W.2007; The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol 171:32–42[CrossRef]
MontanariM.,
BoninsegnaA.,
FaragliaB.,
CocoC.,
GiordanoA.,
CittadiniA.,
SgambatoA.2005; Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors. J Cell Physiol 202:215–222[CrossRef]
MunzB.,
SmolaH.,
EngelhardtF.,
BleuelK.,
BrauchleM.,
LeinI.,
EvansL. W.,
HuylebroeckD.,
BallingR.,
WernerS.1999; Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 18:5205–5215[CrossRef]
ReilandJ.,
FurchtL. T.,
McCarthyJ. B.1999; CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate 41:78–88[CrossRef]
RheinwaldJ. G.,
BeckettM. A.1981; Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41:1657–1665
RotherK.,
DenglM.,
LorenzJ.,
TschopK.,
KirschnerR.,
MossnerJ.,
EngelandK.2007; Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73. FEBS Lett 581:1166–1172[CrossRef]
RuokolainenH.,
PaakkoP.,
Turpeenniemi-HujanenT.2005; Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Clin Cancer Res 11:3257–3264[CrossRef]
ShieldsJ. M.,
Rogers-GrahamK.,
DerC. J.2002; Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J Biol Chem 277:9790–9799[CrossRef]
StevensonD.,
CharalambousC.,
WilsonJ. B.2005; Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. Cancer Res 65:8826–8835[CrossRef]
StewartS.,
DawsonC. W.,
TakadaK.,
CurnowJ.,
MoodyC. A.,
SixbeyJ. W.,
YoungL. S.2004; Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. Proc Natl Acad Sci U S A 101:15730–15735[CrossRef]
Tfelt-HansenJ.,
KanuparthiD.,
ChattopadhyayN.2006; The emerging role of pituitary tumor transforming gene in tumorigenesis. Clin Med Res 4:130–137[CrossRef]
TusherV. G.,
TibshiraniR.,
ChuG.2001; Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98:5116–5121[CrossRef]
WilsonJ. B.,
WeinbergW.,
JohnsonR.,
YuspaS.,
LevineA. J.1990; Expression of the BNLF1-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin-6. Cell 61:1315–1327[CrossRef]